News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
238 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17923)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (238)
2 (224)
3 (92)
4 (10)
5 (10)
6 (214)
7 (239)
8 (198)
9 (219)
10 (75)
11 (6)
12 (5)
13 (153)
14 (234)
15 (200)
16 (201)
17 (76)
18 (17)
19 (6)
20 (153)
21 (186)
22 (178)
23 (191)
24 (66)
25 (2)
26 (2)
27 (155)
28 (199)
29 (173)
30 (238)
31 (108)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Pharm Country
Rallybio to Present at Upcoming Investor Conferences in March
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences.
March 1, 2023
·
1 min read
Drug Development
Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Scholar Rock today announced it will present data from its Phase 2 TOPAZ trial extension period evaluating patient outcomes after 24 months of treatment with apitegromab.
March 1, 2023
·
8 min read
Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023
Edgewise Therapeutics, Inc. today announced that management will present at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023, at 9:10 am ET.
March 1, 2023
·
1 min read
Ronovo wins resounding KOL accolades in latest Carina™ RAS Platform animal labs
Ronovo Surgical invited top gynecology and urology surgeons to evaluate the performance of its newly unveiled Carina™ RAS Platform, the first modular robotic-assisted surgery platform developed in China for laparoscopic procedures.
March 1, 2023
·
6 min read
Biotech Bay
Tachyon Announces Financing and Start of Clinical Study of First-in-Class KDM4 Inhibitor for Advanced Cancers
Tachyon Therapeutics, Inc. today announced the closing of a financing that brings the Company’s total equity financing raises to $11.6 million and, together with a recently announced CIRM grant of $7.1 million, brings total funding in the Company to $18.7 million since the Company started operations in 2020.
March 1, 2023
·
3 min read
Genetown
Alnylam to Webcast Presentations at Upcoming March Investor Conferences - March 1, 2023
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences.
March 1, 2023
·
2 min read
Genetown
Jnana Therapeutics to Participate in Upcoming Investor Conferences
Jnana Therapeutics today announced that management will participate in the following upcoming investor conferences.
March 1, 2023
·
1 min read
FDA
SpectraWAVE Secures 510(k) Clearance of HyperVue™ Intravascular Imaging System
SpectraWAVE, Inc today announced Food and Drug Administration (FDA) 510(k) clearance of their flagship intravascular imaging system, HyperVue™.
March 1, 2023
·
4 min read
Business
Bausch Health Announces Changes to its Board of Directors
Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) today announced that Richard De Schutter and Dr. Argeris Karabelas are retiring from the Company’s Board of Directors, effective as of the upcoming 2023 annual meeting of shareholders of the Company.
March 1, 2023
·
2 min read
BioMidwest
Celcuity to Participate in Cowen’s 43rd Annual Health Care Conference
Celcuity Inc today announced its participation in Cowen’s 43rd Annual Health Care Conference to be held in Boston on March 6-8, 2023.
March 1, 2023
·
1 min read
Previous
11 of 24
Next